Gianvito Salerno, MD
Vascular & Interventional Radiology · Muncie, INNPI 1861524621
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Cook Incorporated at 48.9% of the total. Reporting peaked in 2021 at $6,435 and has fallen 88.6% since, to $732 in 2025.
Across 176 payments — averaging $83.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$7K
- Inari Medical, Inc.$4K
- Cardiovascular Systems Inc.$1K
- Penumbra, Inc.$386
- W. L. Gore & Associates, Inc.$315
- Abbott$251
- plus $963 from 13 others
What the payments were for
- Consulting fees$6,99548%
- Travel & lodging$1,63411%
- Food & beverage$6,01141%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 5 | $7,161 |
| Inari Medical, Inc. | 117 | $4,203 |
| Cardiovascular Systems Inc. | 9 | $1,361 |
| Penumbra, Inc. | 9 | $386 |
| W. L. Gore & Associates, Inc. | 2 | $315 |
| Abbott | 5 | $251 |
| Angiodynamics, Inc. | 3 | $180 |
| Terumo Medical Corporation | 2 | $152 |
| Boston Scientific | 2 | $138 |
| Stryker | 4 | $115 |
| Shockwave Medical, Inc | 4 | $85 |
| Cook Medical LLC | 3 | $67 |
| Reflow Medical Inc | 3 | $66 |
| Bard Peripheral Vascular, Inc. | 2 | $39 |
| Cagent Vascular Inc | 1 | $37 |
| Medtronic | 2 | $32 |
| Imperative Care, Inc | 1 | $21 |
| GSK | 1 | $17 |
| Philips North America LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Torcon NB$3,180
- Peel-Away$2,915
- FLOWTRIEVER CATHETER, S$2,450
- CT THROMBECTOMY SYSTEM KIT$2,161
- Peripheral Orbital Atherectomy System$1,227
- Zilver PTX$900
- Coronary Orbital Atherectomy System$349
- VIABAHN Endoprosthesis$193
- Omnilink Elite vascular stent system$165
- Indigo$141
- Penumbra Ruby Coil$141
- Navicross$138
- EXCLUDER AAA Endoprosthesis$123
- GENERAL VASCULAR INTERVENTION$118
- Auryon Laser System 100-120 Vac$100
How this compares
$14,640 in reported general payments places this provider in the 70th percentile of 74 vascular & interventional radiology providers in Indiana.
See all vascular & interventional radiology providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 21 | $198 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in Muncie
- Jamison WilsonMuncie$8K
- Paul TimpermanWest Lafayette$1.3M
- Daniel SahleinCarmel$845K
- Sabah ButtyMishawaka$275K
- Jeffrey RamkaransinghIndianapolis$274K
- Brandon MartinezFishers$226K
- Nazar GolewaleMerrillville$224K
- Kannan NatarajanIndianapolis$188K
- Katharine KrolLafayette$155K
- Matthew JohnsonIndianapolis$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.